Early weight loss lowers diabetes complications

Losing at least 15% of weight soon after type 2 diabetes diagnosis was associated with fewer vascular complications.
*Retrospective matched cohort study; Level 2 (OCEBM).

Citation

Johnsen E, Bengtsson J, Halasa T, et al. Diabetes Care. 2026;49(8):1480-1489. doi:10.2337/dc26-0937

Background

Substantial early weight loss is increasingly emphasized in type 2 diabetes care, but real-world evidence on later complication risk has been limited.

Patients

Adults aged 18 to 70 years in U.K. primary care with new type 2 diabetes and obesity. Exclusions included prior vascular complications, type 1 diabetes, cancer, thyroid disease, and very rapid weight loss suggesting illness or data error.

Intervention

At least 15% weight loss within 2 years of diagnosis.

Control

Stable weight, defined as less than 2% weight change, matched 4:1 by propensity score.

Outcome

First large-vessel events: heart attack, stroke, angina, or peripheral artery disease. First small-vessel events: chronic kidney disease, retinopathy, or neuropathy.

Follow-up Period

Mean about 7 years.

Results

OutcomeFinding with ≥15% weight loss
Large-vessel complications (primary)Lower risk: hazard ratio 0.86 (95% CI, 0.81-0.91)
Small-vessel complications (primary)Lower risk: hazard ratio 0.90 (95% CI, 0.86-0.94)
Heart attackLower risk: hazard ratio 0.83 (95% CI, 0.77-0.89)
AnginaLower risk: hazard ratio 0.85 (95% CI, 0.78-0.94)
Chronic kidney diseaseLower risk: hazard ratio 0.91 (95% CI, 0.86-0.96)
RetinopathyLower risk: hazard ratio 0.85 (95% CI, 0.78-0.93)

Stroke, peripheral artery disease, and neuropathy were not significantly different. The weight-loss group also had better blood sugar and blood pressure levels despite fewer medicines. Outcomes were analyzed after matching; intention-to-treat is not applicable to this observational study. The control group was stable weight, not an active weight-loss treatment.

Limitations

Observational design prevents proving causation. Healthier behaviors, motivation, diet, or exercise may have differed between groups. Intentional weight loss could not be confirmed directly. Weight and blood tests were recorded during routine care, not at fixed study visits. Findings apply mainly to adults with obesity early after diagnosis, without prior vascular disease.

Funding

Novo Nordisk; several authors employees/shareholders, creating potential bias.

Clinical Application

Prioritize early weight-loss programs for adults with new type 2 diabetes and obesity; do not generalize to longer-standing or non-obese diabetes.